Natera, Inc. CapEx decreased by 38.6% to $22.14M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.5%, from $21.82M to $22.14M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 26.8% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $8.63M | $13.14M | $9.00M | $15.89M | $7.78M | $12.21M | $11.83M | $11.38M | $8.81M | $8.96M | $10.05M | $20.32M | $11.68M | $16.31M | $18.12M | $21.82M | $25.90M | $22.41M | $36.07M | $22.14M |
| QoQ Change | — | +52.2% | -31.5% | +76.4% | -51.0% | +57.0% | -3.1% | -3.8% | -22.6% | +1.7% | +12.2% | +102.1% | -42.5% | +39.7% | +11.1% | +20.4% | +18.7% | -13.5% | +61.0% | -38.6% |
| YoY Change | — | — | — | — | -9.9% | -7.1% | +31.4% | -28.4% | +13.3% | -26.6% | -15.0% | +78.5% | +32.6% | +82.1% | +80.2% | +7.4% | +121.8% | +37.4% | +99.1% | +1.5% |